The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
2021 DORIS definition of remission in SLE: final recommendations from an international task force
Open accessAbstract
Objective: To achieve consensus on a definition of remission in SLE (DORIS). Background: Remission is the stated goal for both patient and caregiver, but consensus on a definition of remission has been lacking. Previously, an international task force consisting of patient representatives and medical specialists published a framework for such a definition, without reaching a final recommendation. Methods: Several systematic literature reviews were performed and specific research questions examined in suitably chosen data sets. The findings were discussed, reformulated as recommendations and voted on. Results: Based on data from the literature and several SLE-specific data sets, a set of recommendations was endorsed. Ultimately, the DORIS Task Force recommended a single definition of remission in SLE, based on clinical systemic lupus erythematosus disease activitiy index (SLEDAI)=0, Evaluator’s Global Assessment <0.5 (0–3), prednisolone 5 mg/day or less, and stable antimalarials, immunosuppressives, and biologics. Conclusion: The 2021 DORIS definition of remission in SLE is recommended for use in clinical care, education, and research including clinical trials and observational studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
van Vollenhoven, R. F., Mosca, M., Bertsias, G., Isenberg, D., Kuhn, A., Lerstrøm, K., Aringer, M., Bootsma, H., Boumpas, D., Bruce, I. N., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-205139 · Cited by 740
Self-citationvan Vollenhoven, R., Voskuyl, A., Bertsias, G., Aranow, C., Aringer, M., Arnaud, L., Askanase, A., Balážová, P., Bonfa, E., Bootsma, H., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209519 · Cited by 367
Self-citationProlonged remission in Caucasian patients with SLE: prevalence and outcomes
Zen, M., Iaccarino, L., Gatto, M., Bettio, S., Nalotto, L., Ghirardello, A., Punzi, L., & Doria, A. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-207347 · Cited by 227
Self-citationTsang-A-Sjoe, M. W. P., Bultink, I. E. M., Heslinga, M., & Voskuyl, A. E. (2017) · Rheumatology · doi:10.1093/rheumatology/kew377 · Cited by 180
Self-citationPetri, M., & Magder, L. S. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40571 · Cited by 175
Self-citationTreat-to-target in rheumatoid arthritis — are we there yet?
van Vollenhoven, R. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0170-5 · Cited by 171
Self-citationZen, M., Iaccarino, L., Gatto, M., Bettio, S., Saccon, F., Ghirardello, A., Punzi, L., & Doria, A. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210154 · Cited by 124
Self-citationUgarte-Gil, M. F., WOJDYLA, D. M., Pons‐Estel, G., Catoggio, L. J., Drenkard, C., Sarano, J. F., Berbotto, G. A., Borba, E. F., Sato, E. I., Brenol, J. C. T., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211814 · Cited by 123
Self-citationRemission in systemic lupus erythematosus: durable remission is rare
Wilhelm, T. R., Magder, L. S., & Petri, M. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209489 · Cited by 114
Self-citationDevelopment of the Asia Pacific Lupus Collaboration cohort
Kandane‐Rathnayake, R., Golder, V., Louthrenoo, W., Luo, S., Wu, Y. J., Li, Z., An, Y., Lateef, A., Sockalingam, S., Navarra, S., et al. (2018) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13431 · Cited by 54
Self-citation
Cited by
CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up
Müller, F., Taubmann, J., Bucci, L., Wilhelm, A., Bergmann, C., Völkl, S., Aigner, M., Rothe, T., Minopoulou, I., Tur, C., et al. (2024) · New England Journal of Medicine · doi:10.1056/nejmoa2308917 · Cited by 1,095
Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus
Mackensen, A., Müller, F., Mougiakakos, D., Böltz, S., Wilhelm, A., Aigner, M., Völkl, S., Simon, D., Kleyer, A., Munoz, L., et al. (2022) · Nature Medicine · doi:10.1038/s41591-022-02017-5 · Cited by 1,092
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Fanouriakis, A., Kostopoulou, M., Andersen, J., Aringer, M., Arnaud, L., Bae, S.-C., Boletis, J., Bruce, I. N., Cervera, R., Doria, A., et al. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224762 · Cited by 1,081
Self-citationCAR T-cell therapy in autoimmune diseases
Schett, G., Mackensen, A., & Mougiakakos, D. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01126-1 · Cited by 430
Complement as a Biomarker for Systemic Lupus Erythematosus
Ayano, M., & Horiuchi, T. (2023) · Biomolecules · doi:10.3390/biom13020367 · Cited by 100
Metadata
- Authors
- van Vollenhoven, R. F., Bertsias, G., Doria, A., Isenberg, D., Morand, E., Petri, M. A., Pons-Estel, B. A., Rahman, A., Ugarte-Gil, M. F., Voskuyl, A., Arnaud, L., Bruce, I. N., Cervera, R., Costedoat-Chalumeau, N., Gordon, C., Houssiau, F. A., Mosca, M., Schneider, M., Ward, M. M., Alarcon, G., Aringer, M., Askanase, A. D., Bae, S.-C., Bootsma, H., Boumpas, D. T., Brunner, H., Clarke, A. E., Coney, C., Czirják, L., Dörner, T., Faria, R., Fischer, R., Fritsch-Stork, R., Inanc, M., Jacobsen, S., Jayne, D., Kuhn, A., van Leeuw, B., Limper, M., Mariette, X., Navarra, S., Nikpour, M., Olesinska, M. H., Pons-Estel, G., Romero-Diaz, J., Rubio, B., Schoenfeld, Y., Bonfá, E., Smolen, J., Teng, Y. K. O., Tincani, A., Tsang-A-Sjoe, M., Vasconcelos, C., Voss, A., Werth, V. P., Zakharhova, E., & Aranow, C.
- Venue
- Lupus Science & Medicine
- Publisher
- BMJ
- Published
- 2021-11
- Volume
- 8
- Issue
- 1
- Pages
- e000538
- ISSN
- 2053-8790 (ISSN-L)
- OpenAlex
- W3215126343
- Cited by
- 386
- References
- 12
- FWCI
- 30.76
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: 2021 DORIS definition of remission in SLE: final recommendations from an international task force. https://app.cochat.ai/papers/10.1136/lupus-2021-000538
- The paper
- van Vollenhoven, R. F., Bertsias, G., Doria, A., Isenberg, D., Morand, E., Petri, M. A., Pons-Estel, B. A., Rahman, A., Ugarte-Gil, M. F., Voskuyl, A., Arnaud, L., Bruce, I. N., Cervera, R., Costedoat-Chalumeau, N., Gordon, C., Houssiau, F. A., Mosca, M., Schneider, M., Ward, M. M., . . . Aranow, C. (2021). 2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus Science & Medicine. https://doi.org/10.1136/lupus-2021-000538
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.